Mode
Text Size
Log in / Sign up
N/A Completed N=22 Treatment

Evaluation of Lotrafilcon A Lenses Over a Three Month Period

Source: ClinicalTrials.gov NCT00931307 ↗
Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Oct 2010
Primary outcomePrimary: Comfort After Insertion — 7.9 Scale of 1 to 10

Summary

The purpose of this trial is to assess the performance of a Lotrafilcon A contact lens over a 3-month period.

Outcome Measures

OutcomeResultp-value
PRIMARY
Comfort After Insertion
7.9 —

Eligibility Criteria

Inclusion Criteria

  • On examination, have ocular findings considered to be "normal" and which would not prevent a subject from safely wearing contact lenses.
  • Be willing and able to follow instructions and meet the schedule of follow-up visits as defined in the informed consent.
  • Be able to wear the study lenses in the available powers.
  • Currently wear contact lenses for a minimum of 5 days a week, and at least 8 hours a day.
  • Other protocol inclusion/exclusion criteria may apply.

Exclusion Criteria

  • Eye injury or surgery within twelve weeks immediately prior to enrollment for this trial.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Currently enrolled in an ophthalmic clinical trial.
  • Evidence of systemic or ocular abnormality, infection or disease likely to affect successful wear of contact lenses or use of their accessory solutions.
  • Any use of medications for which contact lens wear would be contraindicated, in the opinion of the investigator.
  • History of corneal refractive surgery.
  • Other protocol inclusion/exclusion criteria may apply.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00931307). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search